Time-limited therapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:24 5 years ago 93 Далее Скачать
Selection for time-limited & continuous therapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 3:13 2 years ago 100 Далее Скачать
Moving towards time-limited treatment in frontline CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:07 2 years ago 83 Далее Скачать
Optimizing initial therapy in CLL: time-limited, all-oral approaches VJHemOnc – Video Journal of Hematology & HemOnc 1:17 1 year ago 194 Далее Скачать
Clinical trial updates and time-limited therapy in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:59 2 years ago 384 Далее Скачать
Lisaftoclax ramp-up combined with acalabrutinib or rituximab in patients with CLL/SLL VJHemOnc – Video Journal of Hematology & HemOnc 2:36 2 days ago 49 Далее Скачать
Choosing between continuous and time-limited therapy in patients with high-risk CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:56 1 year ago 119 Далее Скачать
An insight into the future treatment landscape of CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:25 2 years ago 144 Далее Скачать
Continuous BTKi therapy in CLL: are time-limited combination therapies more beneficial? VJHemOnc – Video Journal of Hematology & HemOnc 2:56 2 months ago 139 Далее Скачать
Understanding patient perspectives in CLL treatment VJHemOnc – Video Journal of Hematology & HemOnc 5:03 3 years ago 298 Далее Скачать
Insights into the future of the CLL treatment landscape VJHemOnc – Video Journal of Hematology & HemOnc 1:00 5 months ago 135 Далее Скачать
Dr. Woyach on the Utility of Time-Limited Therapies in CLL OncLive 1:05 4 years ago 129 Далее Скачать
Insights into the TARMAC study: time-limited ibrutinib and tisa-cel in patients with R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 5:08 1 year ago 299 Далее Скачать
Targeted therapy in CLL in 2022 and in the future VJHemOnc – Video Journal of Hematology & HemOnc 1:50 2 years ago 1 568 Далее Скачать
CLL treatment duration and the role of MRD VJHemOnc – Video Journal of Hematology & HemOnc 1:44 6 years ago 175 Далее Скачать
Unanswered questions in frontline CLL treatment VJHemOnc – Video Journal of Hematology & HemOnc 0:57 2 years ago 192 Далее Скачать
Insights into the MAJIC study: acalabrutinib + venetoclax vs venetoclax + obinutuzumab in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:50 2 years ago 757 Далее Скачать
Investigating the safety and efficacy of re-treating CLL patients with venetoclax-based regimens VJHemOnc – Video Journal of Hematology & HemOnc 3:33 2 years ago 634 Далее Скачать
